pharmaphorum25d
GSK to lean on Zhifei for Shingrix and maybe Arexvy in China
GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...
Nasdaq1mon
GSK, Zhifei Revise And Extend Strategic Vaccine Collaboration In China
(RTTNews) - GSK plc (GSK, GSK.L), on Thursday, said it has agreed with Chongqing Zhifei Biological Products Ltd. to revise the terms on which Zhifei will commercialize GSK's shingles vaccine ...
London South East1mon
Zhifei China collaboration revised and extended
The revised agreement extends the original 3-year period (2024-2026) during which Zhifei has exclusive rights to import, distribute and co-promote the vaccine in mainland China for an additional 8 ...
Pharmabiz1mon
GSK and Zhifei revise and extend strategic vaccine collaboration in China
GSK plc announced that it has entered into an agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to revise the terms on which Zhifei will commercialise GSK’s shingles vaccine, Shingrix ...